These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 20196631
1. Microencapsulation of sodium alendronate reduces drug mucosal damage in rats. Cruz L, Assumpção E, Andrade SF, Conrado DJ, Guterres SS, Pohlmann AR. Drug Deliv; 2010 May; 17(4):231-7. PubMed ID: 20196631 [Abstract] [Full Text] [Related]
2. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats. Cruz L, Assumpção E, Andrade SF, Conrado DJ, Kulkamp IC, Guterres SS, Pohlmann AR. Eur J Pharm Sci; 2010 Aug 11; 40(5):441-7. PubMed ID: 20471479 [Abstract] [Full Text] [Related]
3. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Sener G, Kapucu C, Cetinel S, Cikler E, Ayanoğlu-Dülger G. Prostaglandins Leukot Essent Fatty Acids; 2005 Jan 11; 72(1):1-11. PubMed ID: 15589394 [Abstract] [Full Text] [Related]
4. Protective effect of taurine against alendronate-induced gastric damage in rats. Sener G, Sehirli O, Cetinel S, Midillioğlu S, Gedik N, Ayanoğlu-Dülger G. Fundam Clin Pharmacol; 2005 Feb 11; 19(1):93-100. PubMed ID: 15660965 [Abstract] [Full Text] [Related]
5. Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery. Cruz L, Fattal E, Tasso L, Freitas GC, Carregaro AB, Guterres SS, Pohlmann AR, Tsapis N. J Control Release; 2011 Jun 30; 152(3):370-5. PubMed ID: 21396412 [Abstract] [Full Text] [Related]
6. Alendronate-loaded microparticles for improvement of intestinal cellular absorption. Baek JS, Kwon HH, Hwang JS, Sung HC, Lee JM, Shin SC, Kim YR, Cho CW. J Drug Target; 2011 Jan 30; 19(1):37-48. PubMed ID: 20477555 [Abstract] [Full Text] [Related]
7. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. Thomson AB, Marshall JK, Hunt RH, Provenza JM, Lanza FL, Royer MG, Li Z, Blank MA, Risedronate Endoscopy Study Group. J Rheumatol; 2002 Sep 30; 29(9):1965-74. PubMed ID: 12233894 [Abstract] [Full Text] [Related]
13. Effects of alendronate on gastric and duodenal mucosa. Lanza F, Rack MF, Simon TJ, Lombardi A, Reyes R, Suryawanshi S. Am J Gastroenterol; 1998 May 30; 93(5):753-7. PubMed ID: 9625122 [Abstract] [Full Text] [Related]
16. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl-beta-cyclodextrin on Wistar rats: histopathologic analysis. Ribeiro-Rama AC, Figueiredo IV, Veiga F, Castel-Branco MM, Cabrita AM, Caramona MM. Fundam Clin Pharmacol; 2009 Dec 30; 23(6):747-55. PubMed ID: 19656206 [Abstract] [Full Text] [Related]
17. Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis. Vachal P, Hale JJ, Lu Z, Streckfuss EC, Mills SG, MacCoss M, Yin DH, Algayer K, Manser K, Kesisoglou F, Ghosh S, Alani LL. J Med Chem; 2006 Jun 01; 49(11):3060-3. PubMed ID: 16722624 [Abstract] [Full Text] [Related]
18. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Graham DY, Malaty HM, Goodgame R. Am J Gastroenterol; 1997 Aug 01; 92(8):1322-5. PubMed ID: 9260798 [Abstract] [Full Text] [Related]